A defining feature of neurodegenerative diseases is the abnormal and excessive loss of neurons. One molecule that is particularly important in promoting neuronal death in a variety of cell culture and in vivo models of neurodegeneration is histone deacetylase-3 (HDAC3), a member of the histone deacetylase family of proteins. As a step towards understanding how HDAC3 promotes neuronal death, we conducted a proteomic screen aimed at identifying proteins that were regulated by HDAC3. HDAC3 was overexpressed in cultured rat cerebellar granule neurons (CGNs) and protein lysates were analyzed by mass spectrometry. Of over 3000 proteins identified in the screen, only 21 proteins displayed a significant alteration in expression. Of these, 12 proteins were downregulated whereas 9 proteins were upregulated. The altered expression of five of these proteins, TEX10, NPTX1, TFG, TSC1, and NFL, along with another protein that was downregulated in the proteomic screen, HIP1R, was confirmed using Western blots and commercially available antibodies. Because antibodies were not available for some of the proteins and since HDAC3 is a transcriptional regulator of gene expression, we conducted RT-PCR analysis to confirm expression changes. In separate analyses, we also included other proteins that are known to regulate neurodegeneration, including HDAC9, HSF1, huntingtin, GAPDH, FUS, and p65/RELA. Based on our proteomic screen and candidate protein approach, we identify three genes, Nptx1, Hip1r, and Hdac9, all known to regulate neurodegeneration that are robustly regulated by HDAC3. Given their suggested roles in regulating neuronal death, these genes are likely to be involved in regulating HDAC3-mediated neurotoxicity.
Introduction
A defining feature of neurodegenerative diseases is the abnormal and excessive loss of neurons. Research conducted over the past decade has shown that treatment with pharmacological inhibitors of histone deacetylases (HDAC) protect against neuronal loss in a wide variety of neurodegenerative diseases. [1] [2] [3] A limitation of the inhibitors used in most of the studies demonstrative neuroprotective action is that they are not selective with regard to which member of the HDAC family of proteins they inhibit. As a result, it has been unclear which HDAC(s) are abnormally activated in neurodegenerative condition and contribute to neuronal loss. A growing body of evidence indicates that HDAC3, a member of the Class I family of HDACs, is particularly important in the promotion of neurodegeneration. [1] [2] [3] First demonstrated in cultured cerebellar granule neurons (CGNs) and in a cell culture model of Huntington's disease (HD), 4 ,5 a growing number of studies have implicated or demonstrated HDAC3 involvement in neurodegeneration. Pharmacological inhibition of HDAC3 using more recently developed and highly selective inhibitors protects against neuronal loss and behavioral deficits
Impact statement
Neurodegenerative diseases are a major medical, social, and economic problem. Recent studies by several laboratories have indicated that histone deacetylase-3 (HDAC3) plays a key role in promoting neuronal death. But the downstream mediators of HDAC3 neurotoxicity have yet to be identified. We conducted a proteomic screen to identify HDAC3 targets the results of which have been described in this report. Briefly, we identify Nptx1, Hip1r, and Hdac9 as genes whose expression is altered by HDAC3. Investigating how these genes are involved in HDAC3 neurotoxicity could shed valuable insight into neurodegenerative disease and identify molecules that can be targeted to treat these devastating disorders.
in mouse models shown in literature. [6] [7] [8] [9] [10] Similar protection against disease pathogenesis has been described in other inherited polyglutamine-expansion disorders, such as spinocerebellar ataxias (SCA).
11 HDAC3 inhibition was also found to protect CA1 hippocampal neurons against oligomeric beta-amyloid-induced impairment of synaptic plasticity and against neuronal loss in cell culture and mouse model of ischemic stroke. 12, 13 A substantial increase in HDAC3 expression along with nuclear localization has been observed soon after the induction of ischemic stroke in mice which if prevented by HDAC3 knockdown protected cortical neurons from OGD-induced death. 12, 14 HDAC3 is highly expressed in the developing and mature brain. 15, 16 Indeed, conditional ablation of HDAC3 in the mouse brain leads to serious neurodevelopmental problems and death within a day to six weeks depending on the extent of ablation. 17 While being necessary for normal brain development, HDAC3 can be converted into a neurotoxic protein through its phosphorylation by GSK3b, its disassociation from normal huntingtin protein, and its interaction with HDAC1. 4, 5, 18 Exactly how the HDAC3-HDAC1 association promotes neuronal death is not known. Interestingly, the toxic effect of HDAC3 is selective for neurons. 4 We have previously described that while primary neurons and neuroblastoma cell lines are sensitive to HDAC3 toxicity, other primary cell types and nonneuronal cell lines are not. 4 As a step towards understanding the mechanism by which HDAC3 promotes neuronal death, we conducted a proteomic analysis to identify genes that were regulated in CGNs by overexpressed HDAC3. As we describe below, this analysis resulted in the identification of several proteins whose expression is altered in neurons by elevated HDAC3. After conducting validation experiments, we analyzed the expression of these genes in HEK293T cells overexpressing HDAC3. We previously described that HEK293T cells are not sensitive to HDAC3 toxicity. 4 
Materials and methods

Materials
Unless stated otherwise, all cell culture media were purchased from Thermo Fisher Scientific (Waltham, MA), and chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO). Poly-L-Lysine for primary neuronal cultures was purchased from R&D Systems (Minneapolis, MN).
Generation of HDAC3 adenovirus
GFP-encoding adenovirus (Ad-GFP) was described previously.
19 HDAC3-FLAG adenovirus (Ad-HDAC3) was generated using ViraPower adenoviral expression system (Thermo Fisher Scientific) following the manufacturer's protocol. Briefly, an HDAC3-FLAG encoding fragment of DNA was amplified using a CMV-HDAC3-FLAG plasmid (Addgene, Cambridge, MA; plasmid number 13819). The primers used are as follows.
Forward: 5-GGGGACAAGTTTGTACAAAAAAGCAG GCTTCACCATGGCCAAGACCGTGGCCTAT-3;
Reverse: 5-GGGGACCACTTTGTACAAGAAAGCTGG GTGTTATTACTTATCGTCGTCATCCTTGTAATC-3.
The fragment containing the HDAC3 coding sequence and the FLAG sequence was cloned into the pDONR221 shuttle vector and then transferred into the adenoviral vector pAd/CMV/V5-DEST. After sequencing, the construct was linearized by PacI and transfected to HEK293A cells (ATCC, Manassas, VA) for virus amplification. The virus was purified using CsCl density gradient centrifugation. CsCl was removed by dialysis against phosphatebuffered saline (PBS) at 4 C for 24 h. After purification, the viral stocks were adjusted to 3 Â 10 10 pfu/mL. The multiplicity of infection for CGNs was 10.
Cell culture and viability assay
CGNs were prepared as previously described using 7-to 8-day-old Wistar rats. 20 The neuronal cultures were plated in Basal Eagle Medium (BME) in 24-well dishes (1 Â 10 6 cells/well for viability assay) or 60 mm dishes (12 Â 10 6 cells/dish for RT-PCR or Western blotting). Five days later, the CGNs were infected with Ad-HDAC3 or Ad-GFP for 2 h in serum-free BME medium containing 25 mM KCl (HK). The virus was then removed and the CGNs were further cultured for 28 or 32 h. The infection rate for HDAC3 and GFP viruses in CGNs was approximately 30% and 40%, respectively. To compare viability, the cells were fixed using 4% paraformaldehyde in PBS and immunocytochemistry was performed. GFP antibody (Santa Cruz Biotechnology, Dallas, TX; catalog # sc-9996) and FLAG antibody (Sigma, catalog # F1804) were utilized to detect GFP and HDAC3, respectively. The secondary antibody Dylight 594 (catalog # 115-585-146) was purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). Staining with 4 0 6-diamidino-2-phenylindole hydrochloride (DAPI) was used to quantify cell viability. Cells with condensed or fragmented nuclei were scored as dead. For each condition, more than 200 infected cells were counted.
HEK293T cells (ATCC) were maintained in DMEM containing 10% FBS, 50 lg/mL streptomycin, and 50 U/mL penicillin. The cells were transfected with GFP plasmid or HDAC3-FLAG plasmid 24 h after plating using EndoFectin (GeneCopoeia, Rockville, MD) following manufacturer's instructions. Thirty hours after transfection, the cells were collected for RT-PCR or Western blotting.
RNA preparation and RT-PCR
RNA was extracted from cultured CGNs or HEK293T cells using TRIzol RNA isolation reagent (Thermo Fisher Scientific) according to the manufacturer's instructions. cDNA was prepared from 3 lg of RNA using the Verso cDNA Synthesis Kit (Thermo Scientific Annealing temperature for each gene was optimized to reduce bias caused by primer mismatch. Amplifying cycles for each mRNA analyzed was adjusted to make sure the reaction is within the exponential amplification phage based on quantification of the signals using a Gel Logic 200 Imaging System (Kodak, Rochester, NY).
Western blot analysis
CGNs or HEK293T cells were lysed in cell lysis buffer and Western blot was performed using standard procedures as we have previously detailed. [21] [22] [23] After blotting on to PVDF membrane, the membrane was first blocked with 5% nonfat milk in TBST buffer (0.05% Tween-20 in 50 mM tris-buffered saline, pH 7.4) at room temperature for 1 h after which it was incubated with primary antibody (1:1000 dilution) at 4 C overnight, followed by secondary antibody (1:10,000 dilution) for 1 h at room temperature. . Immunoreactive bands were detected with Clarity Western ECL substrate (BioRad, Hercules, CA). The Western blot analysis for every protein was repeated at least three times using lysates from separate cultures of neurons or HEK293T cells.
Proteomic analysis
For proteomic analysis, 40 lg proteins from each sample were run on an SDS-PAGE gel for a distance of approximately 10 mm. The gel was stained using Coomassie Blue (R-250) for 1 h. After destaining with 30% methanol, the stained bands representing the full range of protein were cut as a gel slab and transferred to a 1.5 ml tube. The short run and utilization of a single gel slab permitted the digestion and analyses of all cellular proteins together. The single gel slab from different lanes was digested overnight with trypsin (Thermo Fisher Scientific) following reduction and alkylation with DTT and iodoacetamide. The samples then underwent solid-phase extraction cleanup with an Oasis HLB plate (Waters, Milford, MA) and the resulting samples were analyzed by Liquid chromatography-tandem mass spectrometry (LC-MS/MS), using an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific) coupled to an Ultimate, 3000 RSLC-Nano liquid chromatography system (Thermo Fisher Scientific). Samples were injected into a 75 lm i.d., 50 cm long EasySpray column (Thermo Fisher Scientific), and eluted with a gradient of 1-28% buffer B over 60 min. Buffer A contained 2% (v/v) acetonitrile (ACN) and 0.1% formic acid in water, and buffer B contained 80% (v/v) ACN, 10% (v/v) trifluoroethanol, and 0.1% formic acid in water. The mass spectrometer operated in positive ion mode with a source voltage of 2.3 kV and an ion transfer tube temperature of 275 C. Mass spectrometry (MS) scans were acquired at 120,000 resolution in the Orbitrap and up to 10 MS/MS spectra were obtained in the ion trap for each full spectrum acquired using higher energy collisional dissociation (HCD) for ions with charges 2-7. Dynamic exclusion was set for 25 s after an ion was selected for fragmentation.
Raw MS data files were converted to a peak list format and analyzed using the central proteomics facilities pipeline (CPFP), version 2.0.3. 24, 25 Peptide identification was performed using the X!Tandem 26 and Open MS Search Algorithm (OMSSA) 27 search engines against the rat protein database from Uniprot, with common contaminants and reversed decoy sequences appended. 28 Fragment and precursor tolerances of 20 ppm and 0.6 Da were specified, and three missed cleavages were allowed. Carbamidomethylation of Cys was set as a fixed modification and oxidation of Met was set as a variable modification. Label-free quantitation of proteins across samples was performed using SINQ normalized spectral index software. 29 
Bioinformatics
Differentially expressed proteins identified by proteomic analysis were subjected to functional annotation by Ingenuity Pathway Analysis (IPA; http://www.ingenuity. com). IPA is a powerful analysis tool that builds on Ingenuity Knowledge Base and identifies significant pathways and potential regulatory networks associated with differentially expressed proteins.
Statistical analysis
GraphPad Prism 5 software was used for data analyses and the generation of graphs. Unless otherwise mentioned in the figure legends, statistical analysis was done using twotailed t test (Student's t test) and the results were shown as mean AE SD. P < 0.1 was considered as statistically significant for Western blotting and RT-PCR analyses.
Results
Proteomic analysis of CGNs overexpressing HDAC3
Initially, we conducted a time course analysis to identify a time point at which cell death was not significant, but which was followed by significant cell death. The rationale was that at this time point, molecular alterations responsible for inducing cell death would be apparent. For the time course, CGNs were infected with equal amounts of Ad-HDAC3 or Ad-GFP for 2 h in HK after which the virus was removed and cell viability assay was performed at 28, 32, 36, and 40 h. Based on these experiments, we found that there was a sharp increase of cell death in Ad-HDAC3-infected cultures between 28 and 32 h. Repetition of these experiments confirmed that while only 3.9% of the HDAC3-overexpressing neurons were apoptotic at 28 h, and at 32 h, the number was 20.6% (Figure 1(a) and (b) ). Western blot analysis further confirmed that expression of c-JUN, a transcription factor that is often used as a marker of neuronal apoptosis, was elevated in HDAC3-overexpressing CGNs compared to GFP control at 28 h, but not at 24 and 32 h (Figure 1(c) ). Based on these results, we chose to prepare protein lysates from neuronal cultures 28 h after removal of Ad-HDAC3. Lysates from three separate CGN cultures transduced with Ad-GFP or Ad-HDAC3 were prepared. To ensure that the cultures were responding appropriately to ectopic HDAC3 expression, we analyzed an aliquot of the protein lysates for the expression of c-JUN. We confirmed that c-JUN expression was stimulated by Ad-HDAC3 in all three sets of lysates (Figure 1(d) ).
We electrophoresed the lysates briefly on a denaturing gel and a single slab containing all proteins was cut out and sent for proteomic analyses using label-free MSbased approach. A total of 3292 proteins were identified in GFP expressing samples, whereas in HDAC3-overexpressing samples, 3212 were identified. Of these, only 21 proteins showed significant level of changes in HDAC3-overexpressed CGNs compared with GFPexpressing neurons as defined by a change of at least 2-fold and P < 0.05 (Table 1) .
Result validation using Western blot
Based on antibody availability, eight of the differentially expressed proteins were chosen for validation. While five of these proteins, TEX10, NPTX1, TFG, TSC1, and NFL showed a pattern that was consistent with the results from proteomic analysis, expression of PSME2 and PLXNB1 displayed no significant changes. The expression of one protein, PTPRN, showed an increase in expression with HDAC3 overexpression, rather than a downregulation as revealed by proteomic analyses (Figure 2) . We extended our analyses to include HIP1R. Besides being implicated in the regulation of neurodegeneration previously, our proteomic analyses showed that it was robustly downregulated with a ratio of HDAC3/GFP at 0.33 albeit with a P value of 0.052 which was marginally over the cut-off for the rest of the 21 differentially expressed proteins. Immunoblot analysis confirmed that HIP1R was downregulated by HDAC3 (Figure 2 ).
Result validation using RT-PCR
Since HDAC3 is widely regarded as a transcriptional repressor, we also examined mRNA expression of 15 of the 21 differentially expressed proteins in CGN cultures transduced with GFP or HDAC3, including the 8 proteins that we had validated by Western blots (Figure 3) . The choice of the 15 proteins was based on a literature search which indicated their involvement in neuronal function or cellular signaling events. The pattern of change for six of the genes (Ppp2r2d, Smarca2, Nptx1, Plxnb1, Gpd1, and Sec62) was clearly consistent with the pattern observed by proteomic analysis. The mRNA expression of nine other proteins did not display significant changes. RT-PCR analysis also indicated that mRNA levels of Hdac9 and Hip1r were downregulated by HDAC3 (Figure 3) .
Analysis of expression of other proteins of interest
In addition to proteins identified in the MS screen, we examined other protein targets that of interest (Figure 4 ). These proteins were chosen because we or other labs have found them to regulate or be associated with neurodegeneration. These included HDAC9 (a Class II HDAC protein with neuroprotectiveactivity 1, 30 ), HSF1 (a neuroprotective transcription factor 21, 31, 32 ), huntingtin (HTT, mutations of this neuroprotective protein cause HD 5, 33, 34 ), p65/RELA (an NF-jB subunit that can promote both neuronal survival and death [35] [36] [37] ), FUS (mutations and increased expression cause neurodegeneration 38, 39 ) , and GAPDH (a glycolytic protein implicated in promoting neuronal death 40, 41 ). We found that expression of HDAC9 was downregulated by HDAC3 expression (Figure 4) . Surprisingly, given their neuroprotective actions, the expression of HSF1 was increased in HDAC3-overexpressing cultures (Figure 4) . The levels of HTT, p65, FUS, and GAPDH did not change appreciably (Figure 4) .
Analyses of neuronal HDAC3-regulated genes in HEK293T cells
Overexpression of HDAC3 is selectively toxic to neurons and cell lines of neuronal origin. 4 As an attempt to identify changes in gene expression that are related to neurotoxicity, we extended our analyses of mRNA and proteins that were deregulated in neurons to HEK293T cells, which we previously described, are not sensitive to the toxic effect of HDAC3 overexpression. 4 Similar to the proteomic and Western analysis of CGNs, c-JUN was upregulated by HDAC3 in HEK293T cells also ( Figure 5(a) ). Interestingly however, PLXNB1, PSME2, and HDAC9 which are downregulated by HDAC3 in CGNs were significantly elevated in HEK293T cells ( Figure 5(a) ). The other six proteins (TEX10, NPTX1, TFG, TSC1, HIP1R, and HSF1), which were found to be differentially expressed in CGNsoverexpressing HDAC3, showed no significant changes in expression in HEK293T cells ( Figure 5(a) ). We were not able to detect PTPRN and NFL in HEK293T cells using the same antibodies.
We also conducted RT-PCR analysis of RNA isolated from HDAC3-overexpressing HEK293T cells to examine expression of mRNAs that showed differential expression in CGNs ( Figure 5(b) ). As observed in CGNs, the level of HIP1R mRNA was reduced by HDAC3 in HEK293T cells ( Figure 5(b) ). On the other hand, expression of GPD1 ....................................................................................................................................................... ..... Table 1 . Differentially expressed proteins identified by proteomic analysis in HDAC3-overexpressing CGNs. As described in the text, the proteomic analysis was conducted using three sets of lysates prepared from independent neuronal cultures infected either with Ad-HDAC3 or Ad-GFP. Ratio of expression between HDAC3-expressing and GFP-expressing lysates is shown along with p-value, the molecular weight of the protein in daltons (MW [Da] mRNA, which was downregulated in CGNs, was robustly increased by HDAC3 in HEK293T cells. Similarly, PTPRN, also showed a different expression pattern in HEK293 cells-its level was not changed in CGNs, but decreased in HEK293T cells. No significant changes were observed in the expression of mRNA for the six other genes (PPP2R2D, SMARCA2, NPTX1, PLXNB1, SEC62, and HDAC9) that were regulated by HDAC3 in CGNs. Finally, in both CGNs and HEK293T cells, gene expression levels of M4K3, TSC1, TEX10, TFG, RAB23, NFL, EXD2, and PSME2 were not altered by HDAC3. These data show that HDAC3 regulates gene expression differently in neurons versus HEK293T cells. Further work will be necessary to determine the extent to which genes that are regulated differently in neurons compared with HEK293T cells contribute to the selective toxicity of HDAC3 to neurons.
Pathways and functional analysis
To discover significant pathways and potential regulatory networks associated with the differentially expressed proteins, we conducted IPA analysis. Functional analysis by IPA shows that the differentially expressed proteins identified from HDAC3-overexpressing neurons are involved in various molecular and cellular functions, including cellular assembly and organization, cell cycle, cell death and survival, cell morphology, and cell-to-cell signaling and interaction. Fifteen of the 21 differentially expressed proteins are linked in a protein interaction network ( Figure 6 (a)). IPA also shows that 8 of the 21 proteins (NFL, TSC1, NPTX1, PTPRN, PLXNB1, SMARCA2, AK1, and QDPR) play critical roles in neuronal development and function. Top canonical pathways the 21 proteins participate in include AMPK signaling, semaphorin signaling in neurons, and serotonin receptor signaling as shown by IPA ( Figure 6 (b)).
Discussion
Findings from several cell culture and in vivo models indicate that HDAC3 plays a critical role in promoting neuronal death. 4, 5, 7, 9, 16 However, exactly how this neurotoxicity is mediated is not known. As a step towards understanding the underlying mechanisms, we conducted a proteomic analysis of CGNs overexpressing HDAC3. We have previously described that overexpression of HDAC3 promotes death of otherwise healthy CGN cultures and knockdown of HDAC3 protects against low potassium (LK)-induced death of these neurons. 4 Although HDAC3 is a transcriptional repressor, its direct targets would be best identified by methods such as RNA-Seq which identifies changes in RNA expression. Such RNA-Seq analyses for transcriptional targets of HDAC3 have been conducted by other labs using other non-neuronal systems. One potential problem though is the large numbers of mRNA alterations that are detected (generally in the thousands), making it difficult to identify targets that are causally involved in key biological or cellular actions. In this study, we utilized an MS-based proteomic screen, which typically yields a manageable number of changes in protein expression. Moreover, it is the changes in protein expression rather than mRNA alteration that ultimately mediate neurotoxicity or other effects of HDAC3. In our proteomic analysis, we failed to detect 
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c-JUN, a protein that we have found to be regulated by HDAC3 and whose increased expression by HDAC3 was used to confirm that the protein lysates that we were analyzing were from cultures that were responding appropriately. The reason for this is unclear but could be due to the utilization of a single gel slab and in-gel digestion which may have reduced sensitivity of our mass spectrometric analysis. It is also known that signals of low-abundant peptides are often not picked for sequencing by mass spectrometers when many highly abundant peptides exist in the sample and this may have also contributed.
Although HDAC3 is generally believed to be a transcriptional repressor, similar numbers of proteins were identified after GFP and HDAC3 overexpression in CGNs. Of the approximately 3000 proteins identified by an MS analysis, only 21 displayed significantly altered expression with HDAC3 overexpression. Of these proteins, nine were upregulated. It is possible that these changes are secondary to the repression of direct targets of HDAC3. It is noteworthy, however, that recent studies suggest that HDAC3 may also participate in stimulating gene expression. 42 Both upregulation and downregulation of gene expression in comparable numbers has also been described in cells treated with Class I HDAC inhibitors. 43 One of the upregulated proteins of particular interest is NPTX1, a protein that is exclusively localized to the central nervous system.
44
NPTX1 expression is increased in CGNs induced to die by LK-treatment. 45, 46 Expression of NPTX1 is also increased in the brain following hypoxia injury and this increase plays a critical role in hypoxic-ischemic neuronal injury. [47] [48] [49] Indeed, genetic deletion of NPTX1 expression protects mice against neuronal loss resulting from cerebral hypoxia-ischemia and delays neurodegeneration and extends life span in a mouse model of Sandhoff disease, a lysosomal storage disorder characterized by cognitive impairment and ataxia. [50] [51] [52] NPTX1 has also been found to be necessary for amyloid-beta-induced neuronal loss both in cultured cortical neurons and in the mouse brain. 53 Interestingly, both in LK-treated CGNs and following hypoxia, the increase in NPTX1 expression requires GSK3b activity, 45 ,54 which we have previously described, is also required for HDAC3 neurotoxicity. 4 Although further work is needed, these observations suggest that HDAC3 neurotoxicity could be mediated through the stimulation of NPTX1. Another protein that has also been connected to the regulation of neuronal death is HIP1R, which through its association with the clathrin complex is thought to link endocytic machinery to the actin cytoskeleton. 55, 56 A more recent study has found that HIP1R plays a critical role in dendritic development and formation of excitatory synapses. 57 Relevant to this study is the finding that HIP1R promotes cell death through interaction with the pro-apoptotic BCL2 protein, BAK. 58 Given this, it is surprising that rather being induced by HDAC3, our MS, immunoblot, and RT-PCR analyses reveal that suppression of HIP1R by HDAC3. Mutations of HIP1R are associated with Parkinson's disease although whether these mutations increase or reduce HIP1R function is not known. 59 Because of the limited sensitivity of an MS-based protein identification, we complemented our unbiased proteomic analyses with the analyses of several other proteins that we and others have previously described as regulators of neuronal death, including HDAC9, HSF1, p65/RELA, HTT, FUS, and GAPDH. 21, 30, 31, 35, 36, [38] [39] [40] [41] Among these, only HDAC9 showed reduced expression in HDAC3-overexpressing neurons. We have previously shown that HDRP, a smaller form of HDAC9 generated by alternative splicing, plays a key role in promoting neuronal survival and protecting them from apoptotic stimuli. 30, 60 Moreover, overexpression of HDRP suppresses HDAC3 neurotoxicity. 18 Others have found that HDAC9 expression is downregulated after motor neuron denervation and promotes dendritic grown in cortical neurons. 61, 62 It is possible that suppression of HDAC9 expression is involved in HDAC3-mediated neurotoxicity.
We previously described that primary neurons and cell lines of neuronal origin are selectively sensitive to elevated HDAC3. 4 To examine whether the gene expression changes were observed in cells that are not sensitive to HDAC3 toxicity, we used the HEK293T cell line. As described in the results section, most of the mRNA and protein changes that we identified were not observed in HEK293T cells (see Table 2 for qualitative summary of changes in CGNs versus HEK293T cells). This suggests that HDAC3 regulates gene expression differently in different cell types and that at least some of the changes observed in neurons are related to their sensitivity to elevated HDAC3. Consistent with our proposal that altered expression of NPTX1 and HIP1R are targets of HDAC3-mediated neurodegeneration, the expression of both these genes was different in neurons at the protein level ( Figure 5(a) and Table 2 ). Additionally, TSC1 also showed strikingly different patterns of expression in the two cell types after Qu and D'Mello Proteomic analysis of HDAC3-regulated genes in neurons 635 HDAC3 overexpression (Table 2 ). TSC1 is a negative regulator of mTOR signaling, and reduction of mTOR signaling has been implicated in neurodegenerative diseases. 63, 64 In sum, we have identified three proteins, previously implicated in the regulation of neurodegeneration, that are regulated by HDAC3 in neurons-NPTX1, HIP1R, and HDAC9. Further analyses, such as ChIP assays and promoter activity assays, will be necessary to determine if the regulation by HDAC3 is direct or through genes that are directly regulated by HDAC3. Given the growing evidence suggesting that HDAC3 is involved in multiple neurodegenerative conditions, investigating the extent to which NPTX1, HIP1R, and HDAC9 are involved in its neurotoxic effect would be clinically significant. ............................................................................................................................................................ 
